# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Piper Sandler analyst Jessica Tassan initiates coverage on Oscar Health (NYSE:OSCR) with a Overweight rating and announces P...
Wells Fargo analyst Stephen Baxter maintains Oscar Health (NYSE:OSCR) with a Overweight and raises the price target from $24...
B of A Securities analyst Adam Ron downgrades Oscar Health (NYSE:OSCR) from Buy to Neutral and lowers the price target from ...
Baird analyst Michael Ha initiates coverage on Oscar Health (NYSE:OSCR) with a Outperform rating and announces Price Target ...
B of A Securities analyst Adam Ron maintains Oscar Health (NYSE:OSCR) with a Buy and raises the price target from $22 to $25.